Arrowhead Pharmaceuticals's total assets for Q3 2025 were $1.38B, a decrease of -12.26% from the previous quarter. ARWR total liabilities were $666.28M for the fiscal quarter, a -25.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.